Abnormal Uterine Bleeding
- PMID: 28605821
- PMCID: PMC10416181
- DOI: 10.1055/s-0037-1603807
Abnormal Uterine Bleeding
Abstract
Abnormal uterine bleeding is a frequent condition in Gynecology. It may impact physical, emotional sexual and professional aspects of the lives of women, impairing their quality of life. In cases of acute and severe bleeding, women may need urgent treatment with volumetric replacement and prescription of hemostatic substances. In some specific cases with more intense and prolonged bleeding, surgical treatment may be necessary. The objective of this chapter is to describe the main evidence on the treatment of women with abnormal uterine bleeding, both acute and chronic. Didactically, the treatment options were based on the current International Federation of Gynecology and Obstetrics (FIGO) classification system (PALM-COEIN). The etiologies of PALM-COEIN are: uterine Polyp (P), Adenomyosis (A), Leiomyoma (L), precursor and Malignant lesions of the uterine body (M), Coagulopathies (C), Ovulatory dysfunction (O), Endometrial dysfunction (E), Iatrogenic (I), and Not yet classified (N). The articles were selected according to the recommendation grades of the PubMed, Cochrane and Embase databases, and those in which the main objective was the reduction of uterine menstrual bleeding were included. Only studies written in English were included. All editorial or complete papers that were not consistent with abnormal uterine bleeding, or studies in animal models, were excluded. The main objective of the treatment is the reduction of menstrual flow and morbidity and the improvement of quality of life. It is important to emphasize that the treatment in the acute phase aims to hemodynamically stabilize the patient and stop excessive bleeding, while the treatment in the chronic phase is based on correcting menstrual dysfunction according to its etiology and clinical manifestations. The treatment may be surgical or pharmacological, and the latter is based mainly on hormonal therapy, anti-inflammatory drugs and antifibrinolytics.
O sangramento uterino anormal é uma afecção frequente que pode afetar negativamente aspectos físicos, emocionais, sexuais e profissionais, piorando a qualidade de vida das mulheres. Nos casos de sangramento intenso e agudo, as mulheres podem necessitar de tratamento de urgência, com reposição volumétrica e substâncias hemostáticas. Há situações que necessitam de tratamento prolongado, e ainda situações em que o tratamento cirúrgico pode ser necessário. O objetivo deste estudo é descrever as principais evidências sobre o tratamento das mulheres com sangramento uterino anormal, tanto na fase aguda quanto na crônica. A apresentação do tratamento foi baseada no sistema de classificação (PALM-COEIN, na sigla em inglês) da Federação Internacional de Ginecologia e Obstetrícia (FIGO). As etiologias do PALM-COEIN são: Pólipo uterino (P), Adenomiose (A), Leiomiomia (L), lesões precursoras e Malignas do corpo uterino (M), Coagulopatias (C), distúrbios da Ovulação (O), disfunção Endometrial (E), Iatrogênicas (I), e não classificadas nos itens anteriores (N). Os artigos foram selecionados conforme os graus de recomendação das bases de dados PubMed, Cochrane e Embase que tivessem como objetivo o tratamento do sangramento uterino anormal em mulheres. Somente artigos escritos em inglês foram incluídos. Todos os editoriais ou papers completos que não tratassem de sangramento uterino anormal, ou estudos baseados em modelos animais, foram excluídos. O tratamento tem como objetivo a redução do fluxo menstrual, reduzindo morbidade e melhorando a qualidade de vida. O tratamento na fase aguda visa estabilizar hemodinamicamente a paciente e estancar o sangramento excessivo, enquanto a terapia da fase crônica é baseada na correção da disfunção menstrual, conforme sua etiologia ou conforme a manifestação clínica. O tratamento pode ser cirúrgico ou medicamentoso, sendo o segundo baseado principalmente em fármacos hormonais, anti-inflamatórios ou antifibrinolíticos.
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Figures
Similar articles
-
PALM-COEIN Nomenclature for Abnormal Uterine Bleeding.J Midwifery Womens Health. 2016 May;61(3):376-9. doi: 10.1111/jmwh.12440. Epub 2016 Mar 11. J Midwifery Womens Health. 2016. PMID: 26969858
-
Systematic review and meta-analysis of the etiology of heavy menstrual bleeding in 2,770 adolescent females.BMC Womens Health. 2024 Feb 20;24(1):136. doi: 10.1186/s12905-024-02921-7. BMC Womens Health. 2024. PMID: 38378571 Free PMC article.
-
Female Pelvic Conditions: Abnormal Uterine Bleeding.FP Essent. 2022 Apr;515:20-25. FP Essent. 2022. PMID: 35420403
-
FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age.Int J Gynaecol Obstet. 2011 Apr;113(1):3-13. doi: 10.1016/j.ijgo.2010.11.011. Epub 2011 Feb 22. Int J Gynaecol Obstet. 2011. PMID: 21345435
-
Abnormal Uterine Bleeding in Premenopausal Women.Am Fam Physician. 2019 Apr 1;99(7):435-443. Am Fam Physician. 2019. PMID: 30932448 Review.
Cited by
-
Educational Case: Abnormal uterine bleeding.Acad Pathol. 2025 Feb 20;12(1):100160. doi: 10.1016/j.acpath.2025.100160. eCollection 2025 Jan-Mar. Acad Pathol. 2025. PMID: 40059911 Free PMC article. No abstract available.
-
Prediction of Factors Associated with Abnormal Uterine Bleeding by Transvaginal Ultrasound Combined with Bleeding Pattern.Comput Math Methods Med. 2022 Jun 28;2022:5653250. doi: 10.1155/2022/5653250. eCollection 2022. Comput Math Methods Med. 2022. PMID: 35799665 Free PMC article.
-
Diagnostic Value of Vaginal Ultrasound under Improved Clustering Algorithm Combined with Hysteroscopy in Abnormal Uterine Bleeding.Comput Intell Neurosci. 2022 May 27;2022:6951692. doi: 10.1155/2022/6951692. eCollection 2022. Comput Intell Neurosci. 2022. PMID: 35669673 Free PMC article.
-
Prevalence of abnormal uterine bleeding in Brazilian women: Association between self-perception and objective parameters.PLoS One. 2023 Mar 13;18(3):e0282605. doi: 10.1371/journal.pone.0282605. eCollection 2023. PLoS One. 2023. PMID: 36913353 Free PMC article.
-
Abnormal uterine bleeding and associated factors among reproductive age women in Jimma town, Oromia Region, Southwest Ethiopia.Womens Health (Lond). 2022 Jan-Dec;18:17455057221077577. doi: 10.1177/17455057221077577. Womens Health (Lond). 2022. PMID: 35168427 Free PMC article.
References
-
- Liu Z, Doan Q V, Blumenthal P, Dubois R W. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. Value Health. 2007;10(03):183–194. - PubMed
-
- Munro M G, Critchley H O, Fraser I S; FIGO Menstrual Disorders Working Group. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years Fertil Steril 201195072204–2208., 2208.e1–2208.e3 - PubMed
-
- Farquhar C, Ekeroma A, Furness S, Arroll B. A systematic review of transvaginal ultrasonography, sonohysterography and hysteroscopy for the investigation of abnormal uterine bleeding in premenopausal women. Acta Obstet Gynecol Scand. 2003;82(06):493–504. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical